Innovations Abound - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Innovations Abound

Pharmaceutical Technology

Here's a look at some of the most interesting and thematic responses you—our readers—provided for Pharmaceutical Technology's anniversary survey of industry advances and directions.

Which events significantly affected or caused changes in pharmaceutical manufacturing?
"My graduation from college."

"Better chemistry," "gene technology," and "train(ing) dogs to sniff counterfeit drugs" will impact the future direction of pharmaceutical manufacturing.

The rationalization of small-molecule manufacturing facilities in APIs.
"Is the leading edge of pharma."

On the use of information technology:
"There is no replacement for an advanced and validated computerized system."

When it comes to formulation development and manufacturing practices.
"The advice from our management is to have 50% of our workload outsourced—and especially routine work."

Thanks to advanced analytical technologies in NIR.
"(we) don't actually need to prepare the sample tediously."

With regard to the GMPs for the 21st century.
"It's been a long time since 1978, and it is time to update."

"...Most companies have found a way around..."
21 CFR Part 11 regulation.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Source: Pharmaceutical Technology,
Click here